News|Articles|February 21, 2024
Upstream Intensification – Enabling Perfusion Processes with Cell Retention Technologies
Author(s)Millipore Sigma
This white paper provides an overview on an enabling cell retention solution resulting in greater cell-mass to achieve significantly higher titers.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
China Approves First Monthly Biologic for COPD
3
What Are the Benefits of Single-Use in CGT Manufacturing?
4
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
5